These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1391265)

  • 21. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study.
    Yeh TF; Lin HC; Chang CH; Wu TS; Su BH; Li TC; Pyati S; Tsai CH
    Pediatrics; 2008 May; 121(5):e1310-8. PubMed ID: 18426851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A.
    Sun B; Curstedt T; Lindgren G; Franzén B; Alaiya AA; Calkovská A; Robertson B
    Eur Respir J; 1997 Sep; 10(9):1967-74. PubMed ID: 9311487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifications of surfactant phospholipid pattern in premature infants treated with curosurf: clinical and dietary correlations.
    Haumont D; Rössle C; Clercx A; Spehl M; Biver A; Richelle M; Carpentier YA
    Biol Neonate; 1992; 61 Suppl 1():37-43. PubMed ID: 1391264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional residual capacity (FRC) does not predict response to surfactant in preterm infants.
    Dermendjian M; Varma S; Krauss AN; Auld PA
    Am J Perinatol; 2002 Apr; 19(3):155-62. PubMed ID: 12012291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of curosurf for severe respiratory distress syndrome: a case-control study.
    Valls-i-Soler A; Lizarraga M; López de Heredia J; Roman L; Hernáez E; Gastiasoro E
    Biol Neonate; 1992; 61 Suppl 1():21-5. PubMed ID: 1391261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic surface tension of natural surfactant extract under superimposed oscillations.
    Reddy PI; Al-Jumaily AM; Bold GT
    J Biomech; 2011 Jan; 44(1):156-63. PubMed ID: 20883997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional residual capacity and static compliance during the first year in preterm infants treated with surfactant.
    de Winter JP; Merth IT; Brand R; Quanjer PH
    Am J Perinatol; 2000; 17(7):377-84. PubMed ID: 12141525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
    Bhutani VK; Bowen FW; Sivieri EM
    Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.
    Vento G; Pastorino R; Boni L; Cota F; Carnielli V; Cools F; Dani C; Mosca F; Pillow J; Polglase G; Tagliabue P; van Kaam AH; Ventura ML; Tana M; Tirone C; Aurilia C; Lio A; Ricci C; Gambacorta A; Consigli C; D'Onofrio D; Gizzi C; Massenzi L; Cardilli V; Casati A; Bottino R; Pontiggia F; Ciarmoli E; Martinelli S; Ilardi L; Colnaghi M; Matassa PG; Vendettuoli V; Villani P; Fusco F; Gazzolo D; Ricotti A; Ferrero F; Stasi I; Magaldi R; Maffei G; Presta G; Perniola R; Messina F; Montesano G; Poggi C; Giordano L; Roma E; Grassia C; Ausanio G; Sandri F; Mescoli G; Giura F; Garani G; Solinas A; Lucente M; Nigro G; Del Vecchio A; Petrillo F; Orfeo L; Grappone L; Quartulli L; Scorrano A; Messner H; Staffler A; Gargano G; Balestri E; Nobile S; Cacace C; Meli V; Dallaglio S; Pasqua B; Mattia L; Gitto E; Vitaliti M; Re MP; Vedovato S; Grison A; Berardi A; Torcetta F; Guidotti I; di Fabio S; Maranella E; Mondello I; Visentin S; Tormena F
    Trials; 2016 Aug; 17():414. PubMed ID: 27538798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the hemodynamic and respiratory effects of surfactant instillation during interrupted ventilation versus noninterrupted ventilation in rabbits with severe respiratory failure.
    Dijk PH; Heikamp A; Oetomo SB
    Pediatr Res; 1999 Feb; 45(2):235-40. PubMed ID: 10022596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of reconstituted bovine surfactant on pulmonary mechanics in infants with respiratory distress syndrome.
    Tamura M; Kawano T
    Acta Paediatr Jpn; 1989 Dec; 31(6):734-41. PubMed ID: 2516401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surfactant substitution in ventilated very low birth weight infants: factors related to response types.
    Segerer H; Stevens P; Schadow B; Maier R; Kattner E; Schwarz H; Curstedt T; Robertson B; Obladen M
    Pediatr Res; 1991 Dec; 30(6):591-6. PubMed ID: 1805156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of severe respiratory distress syndrome with surfactant].
    Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
    Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects on the pulmonary function after single dose of exogenous pulmonary surfactant in children with acute respiratory distress syndrome].
    de Carvalho WB; Mângia CM
    Rev Assoc Med Bras (1992); 1997; 43(2):145-150. PubMed ID: 9336050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome.
    Rebello CM; Precioso AR; Mascaretti RS;
    Einstein (Sao Paulo); 2014; 12(4):397-404. PubMed ID: 25628188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surfactant status in preterm neonates recovering from respiratory distress syndrome.
    Verlato G; Cogo PE; Balzani M; Gucciardi A; Burattini I; De Benedictis F; Martiri G; Carnielli VP
    Pediatrics; 2008 Jul; 122(1):102-8. PubMed ID: 18595992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.